Putnam Investments’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-31,551
Closed -$1.45M 1334
2017
Q1
$1.45M Sell
31,551
-3,326
-10% -$165K ﹤0.01% 925
2016
Q4
$1.83M Sell
34,877
-277
-0.8% -$13.4K ﹤0.01% 861
2016
Q3
$1.57M Sell
35,154
-30,549
-46% -$1.33M ﹤0.01% 911
2016
Q2
$2.5M Sell
65,703
-5,034
-7% -$221K 0.01% 856
2016
Q1
$2.92M Buy
+70,737
New +$2.92M 0.01% 843

Other funds holding SYNH

Putnam Investments's SYNH Position: Q2 2017 in Review

Putnam Investments sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2017, closing a stake of 31,551 shares — an estimated $1.45M sold.

Putnam Investments first reported a position in SYNH in Q1 2016 and held it in 5 quarters. The position peaked at $2.92M in Q1 2016. 247 funds tracked by Wall St. Rank hold SYNH as of Q2 2017.

  • Putnam Investments reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2017 after selling out during the quarter.
  • Putnam Investments sold 31,551 Syneos Health, Inc. Class A Common Stock shares in Q2 2017, an estimated $1.45M.
  • Putnam Investments first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2016 and held it in 5 quarters.
  • Putnam Investments's Syneos Health, Inc. Class A Common Stock position peaked at $2.92M in Q1 2016.
  • 247 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2017.

Based on Putnam Investments's 13F filing for Q2 2017, filed 14 Aug 2017.